Delivery Order SPE2DB20D3103-SPE2DB25FP6U5
- Not listed
- The Defense Logistics Agency awarded a $1,093.92 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Aripiprazole 1 mg/ml solution in 150ml quantities, with an ultimate completion date of September 2, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under the open market. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.00 to AmerisourceBergen Drug Corp for the supply of Aripiprazole 1 mg/ml solution in a 150 ml quantity. This competitively awarded, firm fixed price delivery order was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Aripiprazole 5 mg tablets. The contract has a potential value of $1,745.77 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation associated with this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with DLA,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 150ml bottles of 1mg/ml Aripiprazole solution. The delivery order has a potential value of $11,520.24 and a completion date of March 5, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of...
- The Defense Logistics Agency awarded a $165,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 tablets of 15 mg aripiprazole. The prime contractor will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by July 27, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen Drug Corporation will perform the order out of its corporate headquarters. No subcontractors or set aside designations were identified....
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $480,000 firm fixed price delivery order by the Defense Logistics Agency to supply 100 count bottles of 5mg Aripiprazole tablets. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle and requires Amerisourcebergen to deliver the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania by August 2, 2023. As the prime contractor,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,764.94 on July 23, 2025, for the supply of Abilify Maintena ER 300 mg vials/syringes/cartridges. This firm fixed price delivery order, with an ultimate completion date of July 24, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The award was not designated as a set-aside contract and was competitively awarded. Performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.07 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Abilify Maintena ER 300 mg syringes. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The award was made on a competitive basis with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $4,531.06 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of September 12, 2025. This is a firm fixed price contract with no set-aside designation, awarded on a competitive basis. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is a firm fixed price delivery order for 4564161107 - ARIPIPRAZOLE 1 MG/ML SOLUTION 150ML, with a ceiling value of $3,701.55 and a performance period through April 4, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceuticals, medical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6U5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Aripiprazole 1 mg/mL solution in a 150 mL quantity at a firm fixed price of $1,743.45. This is a non-set-aside contract utilizing competitive procurement procedures, with an ultimate completion date of July 30, 2025. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The IDC serves as the primary vehicle for supplying pharmaceuticals and medical commodities to support military and veteran healthcare systems globally. AmerisourceBergen's contract portfolio with DLA encompasses an extensive range of therapeutic products, and the company maintains significant capacity as a major federal pharmaceutical distributor supporting Defense Health Agency operations and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/29/25 |